FDA Inspection 712965 — Newpharma, Inc.

Newpharma, Inc. — FEI 1048291

The FDA completed an inspection of Newpharma, Inc. on February 22, 2011 in Miami, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 22, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Miami, FL (United States)